Halozyme Therapeutics shares owned by South Street Advisors
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by South Street Advisors
from 13F filings
Historical chart of South Street Advisors investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by South Street Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Halozyme Therapeutics by South Street Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $18M | 248k | 73.34 |
| 2025-06-30 | $13M | 241k | 52.02 |
| 2025-03-31 | $16M | 244k | 63.81 |
| 2024-12-31 | $11M | 230k | 47.81 |
| 2024-09-30 | $9.8M | 171k | 57.24 |